Blood Collection Tubes Market Size, Trends and Insights By Product Type (Serum Separating Tube, Plasma Separation Tube, Rapid Serum Tubes, Heparin Tubes, EDTA Tubes, Others), By Material (Glass, Plastics), By End User (Diagnostic Centers, Healthcare Centers, Research and Development Centers), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
Study Period: | 2024-2033 |
Fastest Growing Market: | Asia-Pacific |
Largest Market: | Europe |
Major Players
- Becton Dickinson and Company
- Greiner Bio-One International GmbH
- Terumo Corporation
- Sarstedt AG & Co. KG
- QIAGEN N.V.
- Others
Reports Description
Global Blood Collection Tubes Market was valued at USD 2.6 Billion in 2024 and is expected to reach USD 3.8 Billion by 2033, at a CAGR of 3.1% during the forecast period 2024 – 2033.
Blood collection tubes are specialised receptacles used in medical contexts for the gathering, handling, and examination of blood samples. Usually composed of both plastic and glass, these tubes include different coatings or chemicals to help preserve and analyse blood components.
Blood Collection Tubes Market: Growth Factors
Rising number of accidents and injuries
The market for blood collection tubes is growing as a result of an increase in accidents and injuries in several ways. Blood tests are frequently needed by patients after incidents, injuries, or medical crises to evaluate their state, identify injuries, and track their healing. To collect blood samples for examination safely and effectively, healthcare workers need blood collection tubes.
The necessity for quick and precise tests for diagnosis is driving up the need for blood collection tubes together with the frequency of accidents and injuries. The availability of blood collection services in a wider range of healthcare settings has been made possible by developments in medical technology and healthcare infrastructure, which has further fuelled market expansion.
Additionally, people’s growing knowledge of the need for early diagnosis and monitoring of health concerns and healthcare providers contributes to the growing adoption of blood collection tubes, driving market expansion. For instance, for kids and young people aged 5 to 29, automobile accidents are the main cause of mortality.
People in their working years account for two thirds of all traffic deaths (18–59 years old). The WHO African Region has the greatest number of road traffic deaths, while the European Region has the lowest rate. Individuals from poorer socioeconomic origins are more likely to be involved in traffic accidents, even in high-income nations.
Growing incidence of haematological disorders
One of the main factors propelling the blood collection tube market is the rising prevalence of haematological illnesses. Anaemia, leukaemia, and thrombocytopenia are examples of haematological illnesses that are characterised by anomalies in the synthesis, function, or circulation of blood cells.
The need for diagnostic tests and treatments to monitor and manage these ailments is rising in tandem with the ageing population, changing lifestyles, and environmental factors that are contributing to the global prevalence of these disorders.
The collection, storage, and transportation of blood specimens for haematological examination all require the use of blood collection tubes. Blood collection tubes are becoming more and more in demand as medical professionals work to enhance patient care by diagnosing conditions quickly and accurately.
Furthermore, technological developments in blood collecting tubes, including the creation of anticoagulant coatings and vacuum-sealed tubes, further drive market growth by enhancing sample quality and preservation.
For instance, The American Society of Haematology states that an increase to 0.045 for multiple myeloma, 0.016 for leukaemia, 0.012 for non-Hodgkin lymphoma, and 0.002 for Hodgkin lymphoma is anticipated in the incidence rates per 100,000 persons by 2030. There is a distinct trend in the age-standardized death rates for haematological malignancies over the world.
Blood Collection Tubes Market: Restraints
High charge for a storage facility
To preserve sample integrity and stability, blood collection tubes frequently need certain storage conditions, such as regulated temperature and humidity. High storage expenses can have a big effect on wholesalers and producers, raising the total cost of producing blood collection tubes.
This may also result in increased costs for final consumers, such as medical institutions and labs, which might lower demand. High storage costs may also deter smaller laboratories or healthcare providers from keeping enough blood collection tubes on hand, which would restrict their capacity to carry out necessary diagnostic procedures and testing.
Increased storage costs can also present problems for producers in terms of transportation logistics and inventory management, which can further complicate supply chain activities and affect access to markets and competitiveness. In general, excessive storage costs might result in entrance obstacles and constrain market growth within the blood collection tube industry.
Blood Collection Tubes Market: Opportunities
Surge in demand for EDTA Tubes
For several reasons, EDTA (Ethylenediaminetetraacetic Acid) tubes are essential to the growth of the blood collection tube industry. A popular anticoagulant called EDTA effectively keeps blood samples intact by chelating calcium ions and inhibiting the development of blood clots.
Complete blood count (CBC) tests and other haematological investigations benefit greatly from blood sample collection in EDTA tubes because they preserve blood cell shape and guard against cellular deterioration. Furthermore, because they reduce the chance of DNA deterioration, EDTA tubes are recommended for the collection of blood samples for molecular diagnostic procedures like PCR (Polymerase Chain Reaction).
EDTA tubes are a popular alternative for blood collection in a variety of medical contexts due to their adaptability, dependability, and compatibility with different laboratory processes, which has led to their widespread use and contributed to the growth of the blood collection tube market.
For instance, Data from Yourgene Health, an international molecular diagnostics organisation, show that when size selection is used to increase the foetal fraction, extended blood preservation in EDTA tubes is compatible with non-invasive prenatal testing (NIPT).
After using EDTA tubes, scalable and accurate DNA size selection reduces the likelihood of failed screening tests and enhances next-generation sequencing (NGS) procedures, providing a more affordable option to the more costly blood collection tubes (BCTs).
Blood Collection Tubes Market: Segmentation Analysis
Global Blood Collection Tubes market is segmented by product type, material, end user and region. Based on technology, the market is classified into serum separating tube, plasma separation tube, rapid serum tubes, heparin tubes, EDTA tubes, and others.
Serum Separating Tube dominated the market in 2023 with a market share of 26.2% and is expected to keep their dominance during the forecast period 2024-2033 Serum separating tubes play an essential part in driving the blood collection tubes business owing to their distinctive design and functionality.
After centrifugation, the gel barrier or clot activator in these tubes helps separate the serum from the entire blood. Serum, which is abundant in proteins, enzymes, and other analytes, may be efficiently isolated with this method for use in diagnostic tests.
Accurate and dependable laboratory findings are necessary for a range of medical diagnosis and research applications, and the clean separation of serum from cellular components makes this possible. Serum-separating tubes also minimize the danger of contamination or sample deterioration and increase convenience and efficiency in blood collection operations by eliminating the need for extra processing stages.
Based on material, the market is classified into glass and plastics. Plastics dominated the market in 2023 with a market share of 88.5% and is expected to keep its dominance during the forecast period 2024-2033. The market for blood collection tubes is mostly driven by plastics because of their adaptability, low cost, and suitability for use in medical settings.
Blood collection tubes offer a sterile and secure setting for the collection, storage, and transportation of blood specimens. They are commonly composed of polymers like polyethylene terephthalate (PET) or polypropylene (PP). Because plastic tubes are resistant to contamination, breakage, and leaking, they help to preserve the integrity of blood samples while they are being handled and processed.
Furthermore, the shape of tubes may be altered using polymers to satisfy certain lab specifications, including varying dimensions, hues, and anticoagulant or clotting chemicals. Moreover, improving sample stability and preservation are specialized tubes with characteristics like being sealed by vacuum and additive coatings, made possible by technological improvements in the plastic manufacturing industry.
Based on end user, the market is classified into diagnostic centers, healthcare centers, and research and development centers. Diagnostic Centers dominated the market in 2023 with a market share of 55.8% and are expected to keep their dominance during the forecast period 2024-2033.
The market for blood collection tubes is significantly influenced by diagnostic centres because of their crucial function in medical diagnostics. Blood is regularly drawn from these centres for a variety of experiments, such as chemical panels, blood counts, and screens for infectious diseases.
Blood collection tubes are becoming exceedingly in demand as diagnostic testing is used more often for illness diagnosis, monitoring, and treatment. High-quality tubes must be readily available to diagnostic centres to guarantee precise and effective sample handling, collection, and analysis.
Furthermore, the growing diagnostic capabilities and improvements in medical technology are driving up demand for customised blood collection tubes that meet certain testing specifications. As a result, the growing importance of diagnostic centres and the rising number of diagnostic tests conducted greatly contribute to the market growth.
Report Scope
Feature of the Report | Details |
Market Size in 2024 | USD 2.6 Billion |
Projected Market Size in 2033 | USD 3.8 Billion |
Market Size in 2023 | USD 2.5 Billion |
CAGR Growth Rate | 3.1% CAGR |
Base Year | 2023 |
Forecast Period | 2024-2033 |
Key Segment | By Product Type, Material, End User and Region |
Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Blood Collection Tubes Market: Regional Analysis
By region, Blood Collection Tubes market is segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa. North America dominated the global Blood Collection Tubes market in 2023 with a market share of 37.1% and is expected to keep its dominance during the forecast period 2024-2033.
North America has a highly developed healthcare system and a high rate of chronic illnesses, which makes routine blood testing and diagnostic treatments necessary. Additionally, the use of standardised blood collection products and processes is ensured by strict regulatory requirements and a strong framework for healthcare quality assurance.
Furthermore, significant expenditures in research and development, together with the existence of major companies in the medical device sector, spur technical innovation and breakthroughs in blood collection tube layouts and components. The region’s high population density and growing older population further fuel the need for blood collection tubes used in diagnostic procedures.
Blood Collection Tubes Market: Recent Developments
- In April 2022, Blood Centers of America and Fresenius Kabi disclosed a partnership for a national campaign in the US to deliver critical blood collection and blood transfusion supplies to people affected in Ukraine.
- In 2021, Greiner Bio-One designed the MiniCollect PIXIE Heel Incision Safety Lancet within the framework of an effort to diversify its product offering. To accommodate a range of uses, it now provides three distinct varieties of lancets.
- In 2021, Terumo Blood collaborated with CSL Plasma to deliver a novel plasma recuperation platform.
List of the prominent players in the Blood Collection Tubes Market:
- Becton Dickinson and Company
- Greiner Bio-One International GmbH
- Terumo Corporation
- Sarstedt AG & Co. KG
- QIAGEN N.V.
- FL medical s.r.l.
- Narang Medical Limited
- Sekisui Chemical Co. Ltd.
- Improve Medical Instruments Co. Ltd.
- Nipro Corporation
- Biosigma S.p.A.
- Vital Diagnostics
- CML Biotech Pvt. Ltd.
- CDRICHARDS LTD.
- Radiometer Medical ApS
- Thermo Fisher Scientific Inc.
- Narang Medical Limited
- Mindray Medical International Limited
- Grifols S.A.
- Orient Gene Biotech (Beijing) Co. Ltd.
- Others
These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The Blood Collection Tubes Market is segmented as follows:
By Product Type
- Serum Separating Tube
- Plasma Separation Tube
- Rapid Serum Tubes
- Heparin Tubes
- EDTA Tubes
- Others
By Material
- Glass
- Plastics
By End User
- Diagnostic Centers
- Healthcare Centers
- Research and Development Centers
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Blood Collection Tubes Market, (2024 – 2033) (USD Billion)
- 2.2 Global Blood Collection Tubes Market: snapshot
- Chapter 3. Global Blood Collection Tubes Market – Industry Analysis
- 3.1 Blood Collection Tubes Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rising number of accidents and injuries
- 3.2.2 Growing incidence of haematological disorders
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Material
- 3.7.3 Market Attractiveness Analysis By End User
- Chapter 4. Global Blood Collection Tubes Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Blood Collection Tubes Market: Company Market Share, 2023
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Blood Collection Tubes Market – Product Type Analysis
- 5.1 Global Blood Collection Tubes Market Overview: By Product Type
- 5.1.1 Global Blood Collection Tubes Market Share, By Product Type, 2023 and 2033
- 5.2 Serum Separating Tube
- 5.2.1 Global Blood Collection Tubes Market by Serum Separating Tube, 2024 – 2033 (USD Billion)
- 5.3 Plasma Separation Tube
- 5.3.1 Global Blood Collection Tubes Market by Plasma Separation Tube, 2024 – 2033 (USD Billion)
- 5.4 Rapid Serum Tubes
- 5.4.1 Global Blood Collection Tubes Market by Rapid Serum Tubes, 2024 – 2033 (USD Billion)
- 5.5 Heparin Tubes
- 5.5.1 Global Blood Collection Tubes Market by Heparin Tubes, 2024 – 2033 (USD Billion)
- 5.6 EDTA Tubes
- 5.6.1 Global Blood Collection Tubes Market by EDTA Tubes, 2024 – 2033 (USD Billion)
- 5.7 Others
- 5.7.1 Global Blood Collection Tubes Market by Others, 2024 – 2033 (USD Billion)
- 5.1 Global Blood Collection Tubes Market Overview: By Product Type
- Chapter 6. Global Blood Collection Tubes Market – Material Analysis
- 6.1 Global Blood Collection Tubes Market Overview: By Material
- 6.1.1 Global Blood Collection Tubes Market Share, By Material, 2023 and 2033
- 6.2 Glass
- 6.2.1 Global Blood Collection Tubes Market by Glass, 2024 – 2033 (USD Billion)
- 6.3 Plastics
- 6.3.1 Global Blood Collection Tubes Market by Plastics, 2024 – 2033 (USD Billion)
- 6.1 Global Blood Collection Tubes Market Overview: By Material
- Chapter 7. Global Blood Collection Tubes Market – End User Analysis
- 7.1 Global Blood Collection Tubes Market Overview: By End User
- 7.1.1 Global Blood Collection Tubes Market Share, By End User, 2023 and 2033
- 7.2 Diagnostic Centers
- 7.2.1 Global Blood Collection Tubes Market by Diagnostic Centers, 2024 – 2033 (USD Billion)
- 7.3 Healthcare Centers
- 7.3.1 Global Blood Collection Tubes Market by Healthcare Centers, 2024 – 2033 (USD Billion)
- 7.4 Research and Development Centers
- 7.4.1 Global Blood Collection Tubes Market by Research and Development Centers, 2024 – 2033 (USD Billion)
- 7.1 Global Blood Collection Tubes Market Overview: By End User
- Chapter 8. Blood Collection Tubes Market – Regional Analysis
- 8.1 Global Blood Collection Tubes Market Regional Overview
- 8.2 Global Blood Collection Tubes Market Share, by Region, 2023 & 2033 (USD Billion)
- 8.3. North America
- 8.3.1 North America Blood Collection Tubes Market, 2024 – 2033 (USD Billion)
- 8.3.1.1 North America Blood Collection Tubes Market, by Country, 2024 – 2033 (USD Billion)
- 8.3.1 North America Blood Collection Tubes Market, 2024 – 2033 (USD Billion)
- 8.4 North America Blood Collection Tubes Market, by Product Type, 2024 – 2033
- 8.4.1 North America Blood Collection Tubes Market, by Product Type, 2024 – 2033 (USD Billion)
- 8.5 North America Blood Collection Tubes Market, by Material, 2024 – 2033
- 8.5.1 North America Blood Collection Tubes Market, by Material, 2024 – 2033 (USD Billion)
- 8.6 North America Blood Collection Tubes Market, by End User, 2024 – 2033
- 8.6.1 North America Blood Collection Tubes Market, by End User, 2024 – 2033 (USD Billion)
- 8.7. Europe
- 8.7.1 Europe Blood Collection Tubes Market, 2024 – 2033 (USD Billion)
- 8.7.1.1 Europe Blood Collection Tubes Market, by Country, 2024 – 2033 (USD Billion)
- 8.7.1 Europe Blood Collection Tubes Market, 2024 – 2033 (USD Billion)
- 8.8 Europe Blood Collection Tubes Market, by Product Type, 2024 – 2033
- 8.8.1 Europe Blood Collection Tubes Market, by Product Type, 2024 – 2033 (USD Billion)
- 8.9 Europe Blood Collection Tubes Market, by Material, 2024 – 2033
- 8.9.1 Europe Blood Collection Tubes Market, by Material, 2024 – 2033 (USD Billion)
- 8.10 Europe Blood Collection Tubes Market, by End User, 2024 – 2033
- 8.10.1 Europe Blood Collection Tubes Market, by End User, 2024 – 2033 (USD Billion)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Blood Collection Tubes Market, 2024 – 2033 (USD Billion)
- 8.11.1.1 Asia Pacific Blood Collection Tubes Market, by Country, 2024 – 2033 (USD Billion)
- 8.11.1 Asia Pacific Blood Collection Tubes Market, 2024 – 2033 (USD Billion)
- 8.12 Asia Pacific Blood Collection Tubes Market, by Product Type, 2024 – 2033
- 8.12.1 Asia Pacific Blood Collection Tubes Market, by Product Type, 2024 – 2033 (USD Billion)
- 8.13 Asia Pacific Blood Collection Tubes Market, by Material, 2024 – 2033
- 8.13.1 Asia Pacific Blood Collection Tubes Market, by Material, 2024 – 2033 (USD Billion)
- 8.14 Asia Pacific Blood Collection Tubes Market, by End User, 2024 – 2033
- 8.14.1 Asia Pacific Blood Collection Tubes Market, by End User, 2024 – 2033 (USD Billion)
- 8.15. Latin America
- 8.15.1 Latin America Blood Collection Tubes Market, 2024 – 2033 (USD Billion)
- 8.15.1.1 Latin America Blood Collection Tubes Market, by Country, 2024 – 2033 (USD Billion)
- 8.15.1 Latin America Blood Collection Tubes Market, 2024 – 2033 (USD Billion)
- 8.16 Latin America Blood Collection Tubes Market, by Product Type, 2024 – 2033
- 8.16.1 Latin America Blood Collection Tubes Market, by Product Type, 2024 – 2033 (USD Billion)
- 8.17 Latin America Blood Collection Tubes Market, by Material, 2024 – 2033
- 8.17.1 Latin America Blood Collection Tubes Market, by Material, 2024 – 2033 (USD Billion)
- 8.18 Latin America Blood Collection Tubes Market, by End User, 2024 – 2033
- 8.18.1 Latin America Blood Collection Tubes Market, by End User, 2024 – 2033 (USD Billion)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Blood Collection Tubes Market, 2024 – 2033 (USD Billion)
- 8.19.1.1 The Middle-East and Africa Blood Collection Tubes Market, by Country, 2024 – 2033 (USD Billion)
- 8.19.1 The Middle-East and Africa Blood Collection Tubes Market, 2024 – 2033 (USD Billion)
- 8.20 The Middle-East and Africa Blood Collection Tubes Market, by Product Type, 2024 – 2033
- 8.20.1 The Middle-East and Africa Blood Collection Tubes Market, by Product Type, 2024 – 2033 (USD Billion)
- 8.21 The Middle-East and Africa Blood Collection Tubes Market, by Material, 2024 – 2033
- 8.21.1 The Middle-East and Africa Blood Collection Tubes Market, by Material, 2024 – 2033 (USD Billion)
- 8.22 The Middle-East and Africa Blood Collection Tubes Market, by End User, 2024 – 2033
- 8.22.1 The Middle-East and Africa Blood Collection Tubes Market, by End User, 2024 – 2033 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Becton Dickinson and Company
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Greiner Bio-One International GmbH
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Terumo Corporation
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Sarstedt AG & Co. KG
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 QIAGEN N.V.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 FL medical s.r.l.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Narang Medical Limited
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Sekisui Chemical Co. Ltd.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Improve Medical Instruments Co. Ltd.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Nipro Corporation
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Biosigma S.p.A.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Vital Diagnostics
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 CML Biotech Pvt. Ltd.
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 CDRICHARDS LTD.
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Radiometer Medical ApS
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Thermo Fisher Scientific Inc.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Narang Medical Limited
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Mindray Medical International Limited
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Grifols S.A.
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Orient Gene Biotech (Beijing) Co. Ltd.
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 Becton Dickinson and Company
List Of Figures
Figures No 1 to 27
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2033
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
Perspective | Primary research | Secondary research |
Supply-side |
|
|
Demand-side |
|
|
Market Analysis Matrix
Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Becton Dickinson and Company
- Greiner Bio-One International GmbH
- Terumo Corporation
- Sarstedt AG & Co. KG
- QIAGEN N.V.
- FL medical s.r.l.
- Narang Medical Limited
- Sekisui Chemical Co. Ltd.
- Improve Medical Instruments Co. Ltd.
- Nipro Corporation
- Biosigma S.p.A.
- Vital Diagnostics
- CML Biotech Pvt. Ltd.
- CDRICHARDS LTD.
- Radiometer Medical ApS
- Thermo Fisher Scientific Inc.
- Narang Medical Limited
- Mindray Medical International Limited
- Grifols S.A.
- Orient Gene Biotech (Beijing) Co. Ltd.
- Others
FAQs
The restraints of the Blood Collection Tubes market is high charge for storage facility.
The major driver for the Blood Collection Tubes market is rising number of accidents and injuries and growing incidence of haematological disorders.
The “Serum Separating Tube” category dominated the market in 2023.
The key players in the market are Becton Dickinson and Company, Greiner Bio-One International GmbH, Terumo Corporation, Sarstedt AG & Co. KG, QIAGEN N.V., FL medical s.r.l., Narang Medical Limited, Sekisui Chemical Co. Ltd., Improve Medical Instruments Co. Ltd., Nipro Corporation, Biosigma S.p.A., Vital Diagnostics, CML Biotech Pvt. Ltd., CDRICHARDS LTD., Radiometer Medical ApS, Thermo Fisher Scientific Inc., Narang Medical Limited, Mindray Medical International Limited, Grifols S.A., Orient Gene Biotech (Beijing) Co. Ltd., Others.
“North America” had the largest share in the Blood Collection Tubes Market.
The global market is projected to grow at a CAGR of 3.1% during the forecast period, 2024-2033.
The Blood Collection Tubes Market size was valued at USD 2.6 Billion in 2024.